Literature DB >> 21249396

Clinical and laboratory features of Macedonian children with OCRL mutations.

Velibor Tasic1, Vladimir J Lozanovski, Petar Korneti, Nadica Ristoska-Bojkovska, Vesna Sabolic-Avramovska, Zoran Gucev, Michael Ludwig.   

Abstract

OCRL mutations, which are a hallmark of Lowe syndrome, have recently been found in patients with isolated renal phenotype (Dent-2 disease). In this report, we describe clinical and laboratory features in five Macedonian children with mutations in the OCRL gene. Children with a clinical diagnosis of Lowe syndrome or Dent disease underwent complete neurological and ophthalmological examination, imaging of the kidney and urinary tract, assessment of renal tubular function, and mutation analysis of the OCRL gene. Two children (18 months and 11 years, respectively) were diagnosed with Lowe syndrome on the basis of congenital cataracts, severe psychomotor retardation, and renal dysfunction. Both children had low molecular weight proteinuria (LMWP) and hypercalciuria, but not Fanconi syndrome. The older one had bilateral nephrolithiasis due to associated hypocitraturia and mild hyperoxaluria. Three children with asymptomatic proteinuria were diagnosed with Dent-2 disease; none had cataracts or neurological deficit. One child showed mild mental retardation. All had LMWP, hypercalciuria, and elevated enzymes (creatine phosphokinase, lactic dehydrogenase). All three children had an abnormal Tc-99m DMSA scan revealing poor visualization of the kidneys with a high radionuclide content in the bladder; none had nephrolithiasis or nephrocalcinosis. In conclusion, children with OCRL mutations may present with very mild phenotype (asymptomatic proteinuria with/without mild mental retardation) or severe classic oculocerebrorenal syndrome of Lowe. Elevated enzymes and abnormal results on the Tc-99m DMSA scan may be useful indicators for Dent-2 disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21249396     DOI: 10.1007/s00467-010-1758-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  28 in total

1.  End-stage renal failure in Lowe syndrome.

Authors:  Leila Tricot; Yasmina Yahiaoui; Luis Teixeira; Leila Benabdallah; Eugene Rothschild; Jean-Pierre Juquel; Veronique Satre; Jean-Pierre Grünfeld; Dominique Chauveau
Journal:  Nephrol Dial Transplant       Date:  2003-09       Impact factor: 5.992

2.  Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity.

Authors:  C U LOWE; M TERREY; E A MacLACHLAN
Journal:  AMA Am J Dis Child       Date:  1952-02

3.  Poor renal accumulation of 99mTc-DMSA in idiopathic tubular proteinuria.

Authors:  S Suzuki; J Suzuki; K Kume; K Yoshida; H Suyama; Y Kawasaki; R Nozawa; H Suzuki; T Fujiki; S Kamiyama; A Suzuki
Journal:  Nephron       Date:  1999-01       Impact factor: 2.847

4.  Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population.

Authors:  V Matos; G van Melle; O Boulat; M Markert; C Bachmann; J P Guignard
Journal:  J Pediatr       Date:  1997-08       Impact factor: 4.406

5.  Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.

Authors:  P A Jänne; S F Suchy; D Bernard; M MacDonald; J Crawley; A Grinberg; A Wynshaw-Boris; H Westphal; R L Nussbaum
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

6.  Low renal uptake of 99mTc-DMSA in patients with proximal tubular dysfunction.

Authors:  W H van Luÿk; G J Ensing; D A Piers
Journal:  Eur J Nucl Med       Date:  1983

7.  Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.

Authors:  Detlef Bockenhauer; Arend Bokenkamp; William van't Hoff; Elena Levtchenko; Joana E Kist-van Holthe; Velibor Tasic; Michael Ludwig
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-14       Impact factor: 8.237

8.  Locus heterogeneity of Dent's disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations.

Authors:  Enrica Tosetto; Maria Addis; Gianluca Caridi; Cristiana Meloni; Francesco Emma; Gianluca Vergine; Gilda Stringini; Teresa Papalia; Giancarlo Barbano; Gian Marco Ghiggeri; Laura Ruggeri; Nunzia Miglietti; Angela D Angelo; Maria Antonietta Melis; Franca Anglani
Journal:  Pediatr Nephrol       Date:  2009-07-07       Impact factor: 3.714

9.  Dent's disease manifesting as focal glomerulosclerosis: Is it the tip of the iceberg?

Authors:  Yaacov Frishberg; Dganit Dinour; Ruth Belostotsky; Rachel Becker-Cohen; Choni Rinat; Sofia Feinstein; Paulina Navon-Elkan; Efrat Ben-Shalom
Journal:  Pediatr Nephrol       Date:  2009-12       Impact factor: 3.714

10.  Reduced Tc-99m DMSA uptake in a patient with renal tubular acidosis: effect of acid-base imbalance.

Authors:  Meltem Caglar; Rezan Topaloğlu
Journal:  Ann Nucl Med       Date:  2002-11       Impact factor: 2.668

View more
  11 in total

1.  A novel and de novo deletion in the OCRL1 gene associated with a severe form of Lowe syndrome.

Authors:  Ramón Peces; Carlos Peces; Erika de Sousa; Cristina Vega; Rafael Selgas; Julián Nevado
Journal:  Int Urol Nephrol       Date:  2012-07-21       Impact factor: 2.370

Review 2.  Novel techniques and newer markers for the evaluation of "proximal tubular dysfunction".

Authors:  Michael Ludwig; Sidharth K Sethi
Journal:  Int Urol Nephrol       Date:  2011-03-01       Impact factor: 2.370

3.  Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis.

Authors:  Daniela Anne Braun; Jennifer Ashley Lawson; Heon Yung Gee; Jan Halbritter; Shirlee Shril; Weizhen Tan; Deborah Stein; Ari J Wassner; Michael A Ferguson; Zoran Gucev; Brittany Fisher; Leslie Spaneas; Jennifer Varner; John A Sayer; Danko Milosevic; Michelle Baum; Velibor Tasic; Friedhelm Hildebrandt
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-19       Impact factor: 8.237

4.  Novel OCRL mutations in Chinese children with Lowe syndrome.

Authors:  Yan-Qin Zhang; Fang Wang; Jie Ding; Hui Yan; Yan-Ling Yang
Journal:  World J Pediatr       Date:  2013-02-07       Impact factor: 2.764

5.  Incidental Detection of Dent-2 Disease in an Infant with Febrile Proteinuria.

Authors:  Shpetim Salihu; Katerina Tosheska; Svetlana Cekovska; Velibor Tasic
Journal:  Med Princ Pract       Date:  2018-05-17       Impact factor: 1.927

6.  Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins.

Authors:  Kayalvizhi Madhivanan; Swetha Ramadesikan; Wen-Chieh Hsieh; Mariana C Aguilar; Claudia B Hanna; Robert L Bacallao; R Claudio Aguilar
Journal:  Hum Mol Genet       Date:  2020-06-27       Impact factor: 6.150

7.  Muscle involvement in Dent disease 2.

Authors:  Eujin Park; Hyun Jin Choi; Jiwon M Lee; Yo Han Ahn; Hee Gyung Kang; Yoo Mee Choi; Se Jin Park; Hee Yeon Cho; Yong-Hoon Park; Seung Joo Lee; Il Soo Ha; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2014-06-07       Impact factor: 3.714

Review 8.  The oculocerebrorenal syndrome of Lowe: an update.

Authors:  Arend Bökenkamp; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2016-03-24       Impact factor: 3.714

9.  Splicing Analysis of Exonic OCRL Mutations Causing Lowe Syndrome or Dent-2 Disease.

Authors:  Lorena Suarez-Artiles; Ana Perdomo-Ramirez; Elena Ramos-Trujillo; Felix Claverie-Martin
Journal:  Genes (Basel)       Date:  2018-01-04       Impact factor: 4.096

Review 10.  Proteinuria in Dent disease: a review of the literature.

Authors:  Youri van Berkel; Michael Ludwig; Joanna A E van Wijk; Arend Bökenkamp
Journal:  Pediatr Nephrol       Date:  2016-10-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.